OraSure Technologies, Inc.
OSUR
Rank in Stocks
#15801
OraSure Technologies, Inc. and its affiliates are a global leader in the... OraSure Technologies, Inc. and its affiliates are a global leader in the development, production, and commercialization of advanced oral fluid diagnostic solutions and specialized specimen collection tools, serving markets across the United States, Europe, and other international regions. The company operates through two primary divisions: Diagnostics and Molecular Solutions. Its diverse Diagnostics portfolio features a range of crucial offerings, such as the InteliSwab rapid tests for COVID-19 (including professional and prescription versions). It also provides several OraQuick rapid tests, encompassing solutions for HIV (Rapid, In-Home, and Self-Test versions), Hepatitis C (HCV rapid antibody), and Ebola (rapid antigen). Further diagnostic tools include the OraSure oral fluid collection device, utilized for HIV-1 antibody screening and confirmation; the Intercept drug testing systems; various immunoassay tests and reagents; and the Q.E.D. saliva alcohol test. Within its Molecular Solutions segment, OraSure offers an array of genomic products, notably under the Oragene and ORAcollect brand names, alongside specialized microbiome collection solutions and comprehensive GenoFIND genomics laboratory services. The company also supplies collection devices like ORAcollect, RNA, OMNIgene, and RAL, specifically designed for COVID-19 molecular testing. Another key offering is the Colli-Pee device, engineered for the precise volumetric collection of first-void urine. Furthermore, OraSure produces and distributes advanced kits for the collection, stabilization, transportation, and storage of genetic material samples, critical for molecular testing in diverse fields such as academic research, commercial applications (including ancestry, disease risk management, lifestyle analysis), and animal testing. Complementing these, it also provides various other diagnostic tools, including immunoassays and in vitro diagnostic tests. OraSure's sophisticated products and services are distributed to a wide array of clients, including clinical laboratories, hospitals, clinics, various community and public health organizations, wholesale distributors, governmental bodies, medical practices, and a broad spectrum of commercial and industrial entities. Established in 2000, OraSure Technologies, Inc. maintains its corporate headquarters in Bethlehem, Pennsylvania.
Share Price
$3.53
Last synced: 2026-11-09
Market Cap
$243.46M
Change (1 day)
2.62%
Change (1 year)
42.91%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade OraSure Technologies, Inc. (OSUR)
Category
Healthcare
EPS for OraSure Technologies, Inc. (OSUR)
EPS as of June 2026 TTM: $-0.69
According to OraSure Technologies, Inc.'s latest financial reports, its current EPS (TTM) is $-0.69. At the end of 2025 the company had an EPS of $-0.94, a decrease compared to its 2024 EPS of $-0.26.
EPS history for OraSure Technologies, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.69 | -26.60% |
| 2025 | $-0.94 | 261.54% |
| 2024 | $-0.26 | -135.62% |
| 2023 | $0.73 | -392.00% |
| 2022 | $-0.25 | -21.88% |
| 2021 | $-0.32 | 45.45% |
| 2020 | $-0.22 | -181.48% |
| 2019 | $0.27 | -18.18% |
| 2018 | $0.33 | -36.54% |
| 2017 | $0.52 | 48.57% |
| 2016 | $0.35 | 150.00% |
| 2015 | $0.14 | -269.70% |
| 2014 | $-0.08 | -58.75% |
| 2013 | $-0.20 | -31.03% |
| 2012 | $-0.29 | 52.63% |
| 2011 | $-0.19 | 150.99% |
| 2010 | $-0.08 | -55.47% |
| 2009 | $-0.17 | -74.63% |
| 2008 | $-0.67 | -1,440.00% |
| 2007 | $0.05 | -54.55% |
| 2006 | $0.11 | -81.97% |
| 2005 | $0.61 | -4,941.27% |
| 2004 | $-0.01 | -55.79% |
| 2003 | $-0.03 | -67.94% |
| 2002 | $-0.09 | -11.10% |
| 2001 | $-0.10 | -72.22% |
| 2000 | $-0.36 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $8.37 | -1,313.04% |
US
|
|
| $6.02 | -972.74% |
FR
|
|
| $4.15 | -701.45% |
US
|
|
| $5.32 | -871.03% |
JP
|
|
| $1.29 | -286.96% |
CH
|
Questions about OraSure Technologies, Inc.'s earnings per share (EPS)
What is OraSure Technologies, Inc.'s earnings per share (EPS)?
OraSure Technologies, Inc.'s earnings per share (EPS) over the last twelve months is $-0.69, as of Jun 2026.
What was OraSure Technologies, Inc.'s earnings per share (EPS) in 2025?
In 2025, OraSure Technologies, Inc.'s earnings per share (EPS) was $-0.94, compared with $-0.26 in 2024.
How has OraSure Technologies, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, OraSure Technologies, Inc.'s earnings per share (EPS) was highest in 2023 ($0.73) and lowest in 2025 ($-0.94).
How does OraSure Technologies, Inc.'s earnings per share (EPS) compare with similar companies?
OraSure Technologies, Inc.'s earnings per share (EPS) ($-0.69) is lower than that of all 5 similar companies listed above. The highest among them is Intuitive Surgical, Inc., with $8.37.